Published Online
on June 30, 2008

A more recent version of this article appeared on August 1, 2008

This Article Full Text (PDF) All Versions of this Article: 52/2/209    most recent HYPERTENSIONAHA.108.115733v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Graf, K. Articles by Stawowy, P. PubMed PubMed Citation Articles by Graf, K. Articles by Stawowy, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB SPIRONOLACTONE Related Collections Hypertrophy Remodeling Related Article

Cardiac Benefits of Mineralocorticoid Receptor Inhibition in Renal Failure

Kristof Graf^*; Thomas Hucko; and Philipp Stawowy

From the Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany.

^* To whom correspondence should be addressed. E-mail: graf{at}dhzb.de.

Related Article:

Mineralocorticoid Receptor Antagonism Attenuates Cardiac Hypertrophy and Prevents Oxidative Stress in Uremic Rats

Luis Michea, Andrea Villagrán, Alvaro Urzúa, Sonia Kuntsmann, Patricio Venegas, Loreto Carrasco, Magdalena Gonzalez, and Elisa T. Marusic
Hypertension 2008 52: 295-300. [Abstract] [Full Text] [PDF]